Suppliers / Santisa Laboratorio Farmaceutico

Santisa Laboratorio Farmaceutico

Brazil 228 employees Updated 9 July 2026

Santisa Laboratorio Farmaceutico is a finished-dose manufacturer based in Brazil. It appears in 75 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by ANVISA (Brazil).

0
active US DMFs
0
valid CEPs
1
registered plants
75
filings across 1 regulators

Registered plants

Site FDA FEI
BAURU, Brazil Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
ANVISA (Brazil) 75 3

Questions about Santisa Laboratorio Farmaceutico

Does Santisa Laboratorio Farmaceutico hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Santisa Laboratorio Farmaceutico. It does have 75 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Santisa Laboratorio Farmaceutico manufacture?
1 registered site is on record, in Brazil (Bauru). Every site is listed on this page with the register it came from.
Which regulators recognise Santisa Laboratorio Farmaceutico's GMP?
Current GMP certificates are on record from ANVISA (Brazil). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Santisa Laboratorio Farmaceutico comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates